Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings
Phase 2
Recruiting
- Conditions
- COVID-19.COVID-19U07.01
- Registration Number
- IRCT20200408046988N1
- Lead Sponsor
- Gonabad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Consent to participate in the study
Confirmed and suspicious COVID-19 patients
Not participating in another clinical trial plan simultaneously
Exclusion Criteria
Lack of consent for the study
Changing the other routine medications during the project
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Confirmed and possible Coronavirus 2019. Timepoint: at the time of admission. Method of measurement: CT scan - PCR test Corona virus.
- Secondary Outcome Measures
Name Time Method aboratory study. Timepoint: daily. Method of measurement: CBC diff-ABG.